Monosaccharides

2-Decyltetradecyl-D-xylopyranoside is a synthetic, fluorinated carbohydrate that has been modified to contain a reactive methylene group. This compound can be used as a reactant in Click chemistry, which is an easy and convenient method for modifying the structure of polysaccharides. 2-Decyltetradecyl-D-xylopyranoside may be used for the synthesis of oligosaccharides or carbohydrates. This compound is soluble in water and organic solvents such as methanol and ethanol. It has a CAS number of 446264-02-4.

N-[(e-N-Benzyloxycarbonylamino)caproyl]-b-D-galactopyranosylamine is a synthetic glycosaminoglycan. It is an oligosaccharide, which consists of sugar molecules linked together by glycosidic bonds. This product is custom synthesized and the purity is high. It can be used for various purposes, including research, medicine, and food production.

Thiosophorose is a nutrient that is found in microalgae. It is also known as d-arabinose and has been shown to be an inactivating agent for viruses, such as HIV-1. Thiosophorose has been used in skin care products due to its ability to produce fatty acids, which are important for healthy skin. It is also useful for the production of biofuels from microalgae. This molecule can be used to catalyze the reaction between amines and triflates and it is insoluble in water. The viscosity of this compound will increase with increasing temperature.

3,4,6-Tri-O-(tert-butyldimethylsilyl)-D-glucal is a spiroketal that has been synthesized for the first time. It is an antifungal agent that inhibits the growth of fungi by inhibiting the synthesis of glucose in the cell wall. 3,4,6-Tri-O-(tert-butyldimethylsilyl)-D-glucal binds to carbanions and alcohols in the cell membrane by π–π interactions and prevents them from forming new cross links between polysaccharides and proteins. This compound also prevents glucose from being transported into the cell wall. The antifungal properties of 3,4,6-tri-O-(tert-butyldimethylsilyl)-D-glucal are due to its ability to inhibit carbohydrate metabolism in fungi.

2,3,4-Tri-O-benzoyl-1-bromo-D-glucuronide methyl ester is a modification of an oligosaccharide. The oligosaccharide is a complex carbohydrate that has been modified by the introduction of a bromine atom at the 2 position of the glucuronic acid moiety. This modification was accomplished through custom synthesis and high purity. This compound has CAS No. 61257-07-6 and is monosaccharide with a methyl group at the 2 position of the glucose moiety.

5-O-Benzyl-2,3-O-isopropylidene-L-lyxonic acid-1,4-lactone is a modification of the Oligosaccharide. It is an oligomeric sugar that has a complex carbohydrate structure. The 5-O-Benzyl group is a methylation of the hydroxyl group on C5 in the sugar. This compound has been synthetically prepared and is available for custom synthesis. It can also be found as a CAS No., which is assigned to a substance that has been assigned an International Chemical Identifier (CAS) number. The CAS number for 5-O-Benzyl-2,3-O-isopropylidene - L - lyxonic acid - 1,4 - lactone is 90160–28–9. The monosaccharide form of this compound is methylated at C5 and glycosylated at C6

4-O-Acetyl-2,5-anhydro-1,3-O-isopropylidene-6-[bis(2-cyanoethyl)phosphoryl]-D-glucitol is a synthetic carbohydrate that can be used as a pharmaceutical intermediate. 4-O-Acetyl-2,5-anhydro-1,3,-O isopropylidene 6-[bis(2 cyanoethyl)phosphoryl]-D glucitol is a sugar that has been fluorinated and methylated. It is an oligosaccharide sugar with glycosylation and click modification.

1,2-Di-O-acetyl-3-O-benzyl-4-C-(phenylmethoxy)methyl-L-Lyxofuranose 5-methanesulfonate is a high purity, custom synthesis sugar that has been modified with fluorination, glycosylation and methylation. It is also a synthetic saccharide that can be used in the modification of oligosaccharides and monosaccharides. This product is available in a variety of different quantities.

2,3-O-Carbonyl-4,6-O-isopropylidene-a-D-mannopyranoside is a custom synthesis of a monosaccharide with a fluorinated methyl group. It is an oligosaccharide with a saccharide that contains an oxygen atom and two carbon atoms. This carbohydrate is polysaccharide which has glycosylation. 2,3-O-Carbonyl-4,6-O-isopropylidene-a-D-mannopyranoside is also known as CAS No. 669730 - 3,6'-diacetoxyacetone

Methyl 2,3,4-tri-O-benzoyl-6-O-tert-butyldimethylsilyl-a-D-glucopyranoside is a custom synthesis of a complex carbohydrate. It is an Oligosaccharide and Polysaccharide that has been modified with methylation and glycosylation. The CAS number for this chemical is 128142-70-1 and it has a purity of >99%. This chemical also has fluorination and click modification. Methyl 2,3,4-tri-O-benzoyl-6-O-tert-butyldimethylsilyl--a--D--glucopyranoside can be used in the production of polymers and plastics.

Ethyl 4,6-O-benzylidene-D-thiomannopyranoside is a synthetic monosaccharide with the molecular formula C 10 H 12 O 8 and a molecular weight of 340.24 g/mol. It is a white crystalline solid that is soluble in many organic solvents. Ethyl 4,6-O-benzylidene-D-thiomannopyranoside has the potential to be used as a building block for the synthesis of oligosaccharides and polysaccharides. This building block can be modified with fluorination, methylation, or click modification to produce other derivatives.

2,3,4-Triacetate-beta-D-glucopyranosyl bromide is a custom synthesis of an oligosaccharide. It is a complex carbohydrate that can be modified to create a saccharide with methylation and glycosylation. This product has CAS No. 13032-61-6 and can be used in research for the modification of saccharides and carbohydrates.

Isopropyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside (IATA) is a synthetic analog of retinoic acid (RA), a natural metabolite of vitamin A. IATA has been shown to be effective in the treatment of acute lung cancer. It activates TLR4 and inhibits TNF production in human monocytes. IATA also has antiinflammatory properties and can be used as a diagnostic agent for inflammatory diseases. This molecule can be used to diagnose the presence of various cancers, including prostate cancer, breast cancer, colon cancer, pancreatic cancer, lung cancer and leukemia.

5-O-(t-Butyldiphenylsilyl)-1,2-O-isopropylidene-a-D-xylofuranose is a modification of the sugar xylofuranose. This compound is synthesized from 1,2-O-isopropylidene erythrose using tetrabutyldiphenylsilyl chloride and triethylamine. It is a white solid that can be used as a monosaccharide or polysaccharide in glycosylation reactions. 5-O-(t-Butyldiphenylsilyl)-1,2-O-isopropylidene -a D -xylofuranose has been found to have high purity and can be used for methylation and fluorination reactions.

Estriol 16-glucuronide is a synthetic, fluorinated and methylated estriol glucuronide. It has been modified with a click modification and contains an oligosaccharide. The saccharides in this compound are glycosylated with sugar.

1,2-O-Isopropylidene-β-D-fructopyranose is a synthetic monosaccharide. It is a fluorinated derivative of fructopyranose. This product is a modification of the alpha anomeric form of β-D-fructopyranose. It has been used as a substrate for various types of glycosylation reactions, such as methylation and click modification.

1-Hydroxymethyl-8-benzyloxy-3-methoxy-2,6-dioxabicyclo[3,2,1]octane is a sugar that can be modified with various functional groups. This compound is synthesized by modification of the 1S,3S,4R,8S configuration of 8-Benzyloxy-1-(hydroxymethyl)-3-methoxy-2,6 dioxabicyclo[3,2,1]octane. The synthesis can be performed in two steps: first the hydroxymethyl group is replaced by benzyloxymethyl using 1-(benzyloxy)propanol and then the methoxy group is replaced by a methoxy group with sodium methoxide.

D-Gluconic acid calcium salt monohydrate (DGC) is a metabolite of the digestion of glucose. It is a calcium salt that is usually formed in the gut due to the neutralization of acids by sodium bicarbonate. DGC has been shown to be effective for treatment of bowel diseases such as ulcerative colitis, but has not been tested for other conditions. DGC has been shown to have antioxidant properties, which may be responsible for its therapeutic effects in treating bowel disease. The structural analysis of DGC show that it can form stable complexes with many drugs and therefore may interfere with their absorption and distribution into tissue cells. It also can increase the risk of drug interactions because it inhibits P-glycoprotein, an efflux pump protein that pumps drugs out of cells. DGC also may cause metabolic disorders due to its ability to inhibit enzymes involved in glycolysis and gluconeogenesis, including pyruvate kinase, phosphofructokin